Detalhe da pesquisa
1.
Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection.
Antimicrob Agents Chemother
; 66(1): e0170421, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662184
2.
Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
Antimicrob Agents Chemother
; 66(1): e0170321, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34723626
3.
Once-Daily Plazomicin for Complicated Urinary Tract Infections.
N Engl J Med
; 380(8): 729-740, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30786187
4.
Bactericidal activity, absence of serum effect, and time-kill kinetics of ceftazidime-avibactam against ß-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 58(9): 5297-305, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957838
5.
Pathogens susceptible to tetracycline are also susceptible to omadacycline: tetracycline as a one-sided surrogate to predict omadacycline susceptible pathogens.
Diagn Microbiol Infect Dis
; 104(3): 115785, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988350
6.
Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.
Infect Dis Ther
; 6(2): 233-243, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285420
7.
Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function.
Thromb Haemost
; 94(5): 1019-27, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16366002
8.
Effect of In Vitro Testing Parameters on Ceftazidime-Avibactam Minimum Inhibitory Concentrations.
Int Sch Res Notices
; 2015: 489547, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-27347525
9.
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents.
PLoS One
; 8(4): e60579, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23577127
10.
Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.
J Infect Dis
; 198(9): 1398-406, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18754742
11.
Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome.
Infect Immun
; 75(3): 1229-36, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17220320
12.
CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.
Am J Pathol
; 170(2): 526-37, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255321
13.
A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease.
J Am Soc Nephrol
; 17(12): 3404-14, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17082244
14.
The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells.
J Immunol
; 169(8): 4496-503, 2002 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12370386